Date: May 14th 2019
Local: Centro de Treinamento do INRAD
http://centrodetreinamentoinrad.hc.fm.usp.br/
Chairs:
Raymond F. Schinazi, PhD, DSc
Frances Winship Walters Professor of Pediatrics at Emory and director of the Laboratory of Biochemical Pharmacology. - Emory University
Suzane Kioko Ono, MD, Phd
Department of Gastroenterology - University of São Paulo School of Medicine
Division of Clinical Gastroenterology and Hepatology - Hospital das Clínicas FMUSP
AIM:
To advance our knowledge of the ongoing drug development processes and opportunities from academia to real world. Focus on academic-industrial partnerships for translation of technologies.
Target audience
This program is designed to meet the educational needs of researchers, post-graduated students and professionals from industry involved in the drug discovery and development in Brazil.
Topics of Discussion
Academia and Industry partnership in drug discovery and development
Start-ups role in drug discovery and development
Drug Discovery - from Brazil to Global experience
Drug Development - Brazil solutions
PRELIMINARY PROGRAM
May 14th 2019.
13:00 - Registration
14 hs - Oppening
Suzane K Ono & Raymond Schinazi
14:10h - Suzane K Ono
From Patient to Bench to Patient - The case of HBV
14:30 - Academia-pharma partnership for novel drug discovery - The case of CENTD
Presenter: Ana Marisa Chudzinski-Tavassi - Center of Excellence in New Target Discovery (CENTD) coordinator and Director of Innovation at Butantan Institute
14:50 - Bionformatic and Drug Discovery - The case of NAIAD Drug Design
Presenter: Ricardo di Lazzaro - Co-founder of technology and biotechnology companies: AppSimples, VR Monkey, LOTAN Agrosciences, MaChiron and NAIAD.
15:10 - Brazil-based pharmaceutical company & drug discovery - The case of EMS
Presenter: Dan Salazar - Chief Science Officer, Board of Directors, EMS S/A
15:30 - Development of Active Pharmaceutical Ingredients (APIs) for the domestic pharmaceutical industry - The case of Microbiológica
Presenter: Jaime Rabi - Executive Director at Microbiologica, Química e Farmacêutica Ltda
Plenary talk:
15:50 - Disruptive Discoveries for HIV, HCV and HBV Infections
Presenter: Raymond Schinazi
16:40 - Round table & discussion - all
17:30 - Closing remarks